[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

July 2019 | 167 pages | ID: LAD69F72147EN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
“Technological advancements, the need for improved data standardization, and the growing adoption of analytics solutions in clinical trials are the key factors driving the life science analytics market.”

The life science analytics market is projected to reach USD 33.2 billion by 2024 from USD 19.3 billion in 2019, at a CAGR of 11.5% during the forecast period. Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, and growing pressure to curb healthcare spending. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent

“Prescriptive analytics segment to grow at the highest CAGR during the forecast period.”

Based on type, the life science analytics market is segmented into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest share of the life science analytics market in 2018, while the prescriptive analytics segment is projected to grow at the highest CAGR during the forecast period due to its ability to ensure the synergistic integration of predictions and prescriptions.

“Services segment accounted for the largest share of the life science analytics market in 2019.”

On the basis of component, the life science analytics market is segmented into services and software. The services segment accounted for the largest market share in 2018 and is expected to register the highest growth during the forecast period. The large share and high growth in this segment can be attributed to the recurring need for services such as software upgrades and maintenance.

“Asia to be the fastest-growing regional market.”

By region, the life science analytics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share in 2018. The large share of this market is attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. However, Asia is expected to grow at the highest CAGR during the forecast period. Factors such as growing R&D investments, increase in drug development-based research, rising pressure to comply with regulatory requirements, and low manufacturing costs in the region are supporting the growth of the life science analytics market in Asia.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
  • By Designation: C-level (30%), D-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), Asia (20%), and the RoW (12%)
List of Companies Profiled in the Report
  • IBM Corporation (US)
  • SAS Institute, Inc. (US)
  • Oracle Corporation (US)
  • Quintiles, Inc. (US)
  • Accenture (Ireland)
  • Cognizant (US)
  • Wipro Limited (India)
  • MaxisIT Inc. (US)
  • TAKE Solutions (India)
  • SCIO Health Analytics (US)
Research Coverage:

This report provides a picture of the life science analytics market. It aims at estimating the size and future growth potential of the market across different segments, such as type, component, deployment model, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall life science analytics market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY SOURCES
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY SOURCES
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW
4.2 LIFE SCIENCE ANALYTICS MARKET, BY TYPE
4.3 LIFE SCIENCE ANALYTICS MARKET, BY END USER
4.4 GEOGRAPHIC SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
  5.1.1 DRIVERS
    5.1.1.1 Technological advancements
    5.1.1.2 Big data in the life science industry
    5.1.1.3 Growing adoption of analytics solutions in clinical trials
    5.1.1.4 Increasing adoption of analytics for sales and marketing applications
    5.1.1.5 Need for improved data standardization
    5.1.1.6 Increasing prevalence of chronic diseases
    5.1.1.7 Growing pressure to curb healthcare spending and the need for improved patient outcomes
  5.1.2 RESTRAINTS
    5.1.2.1 High implementation costs
  5.1.3 OPPORTUNITIES
    5.1.3.1 Increasing focus on value-based medicine
    5.1.3.2 Use of analytics in precision and personalized medicine
    5.1.3.3 Use of big data analytics to increase R&D productivity
    5.1.3.4 Emergence of social media and its impact on the life science industry
  5.1.4 CHALLENGES
    5.1.4.1 Data privacy issues
    5.1.4.2 Data integration in the life science ecosystem
    5.1.4.3 Dearth of skilled personnel

6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE

6.1 INTRODUCTION
6.2 DESCRIPTIVE ANALYTICS
  6.2.1 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET
6.3 PREDICTIVE ANALYTICS
  6.3.1 PREDICTIVE ANALYTICS SOLUTIONS CAN HELP INCREASE THE ACCURACY OF DATA
6.4 PRESCRIPTIVE ANALYTICS
  6.4.1 PRESCRIPTIVE ANALYTICS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD

7 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 RESEARCH & DEVELOPMENT
  7.2.1 CLINICAL TRIALS
    7.2.1.1 Need to streamline clinical trials and reduce the time and cost of drug development to drive the demand for analytics solutions
  7.2.2 PRECLINICAL TRIALS
    7.2.2.1 Analytics solutions for preclinical trials help in the entire discovery and research value chain
7.3 SALES & MARKETING
  7.3.1 SALES & MARKETING ANALYTICS ARE ESSENTIAL TO INCREASE REVENUE AND PROFITABILITY
7.4 PHARMACOVIGILANCE
  7.4.1 PLAYERS OPERATING IN THIS SEGMENT ARE INCREASINGLY FOCUSING ON NEW PRODUCT LAUNCHES
7.5 REGULATORY COMPLIANCE
  7.5.1 STRINGENT REQUIREMENTS HAVE SUPPORTED THE NEED FOR COMPLIANCE ADHERENCE SOLUTIONS
7.6 SUPPLY CHAIN OPTIMIZATION
  7.6.1 GROWING NEED TO REDUCE LOGISTICS COSTS TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS

8 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT

8.1 INTRODUCTION
8.2 SERVICES
  8.2.1 SERVICES FORM A LARGER COMPONENT OF THE LIFE SCIENCE ANALYTICS MARKET
8.3 SOFTWARE
  8.3.1 LIFE SCIENCE ANALYTICS SOFTWARE SOLUTIONS ENABLE PHARMA-BIOTECH COMPANIES AND MEDICAL DEVICE COMPANIES TO MANAGE CLINICAL TRIALS DATA AND PROVIDE SALES AND MARKETING SUPPORT

9 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL

9.1 INTRODUCTION
9.2 ON-PREMISE DELIVERY MODEL
  9.2.1 ON-PREMISE SOLUTIONS OFFER MULTIVENDOR ARCHITECTURE, WHICH LOWERS THE RISK OF DATA BREACHES & EXTERNAL ATTACKS
9.3 ON-DEMAND DELIVERY MODEL
  9.3.1 INCREASING VOLUME OF DATA GENERATED ACROSS THE LIFE SCIENCE INDUSTRY WILL DRIVE THE ADOPTION OF ON-DEMAND SOLUTIONS

10 LIFE SCIENCE ANALYTICS MARKET, BY END USER

10.1 INTRODUCTION
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  10.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
10.3 MEDICAL DEVICE COMPANIES
  10.3.1 ADOPTION OF BIG DATA ANALYTICS IS HELPING MEDICAL DEVICE MANUFACTURERS TO SECURE A COMPETITIVE ADVANTAGE IN THE INDUSTRY
10.4 RESEARCH CENTERS
  10.4.1 INCREASING RESEARCH ACTIVITIES TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS IN THIS END-USER SEGMENT
10.5 THIRD-PARTY ADMINISTRATORS
  10.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT

11 LIFE SCIENCE ANALYTICS MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
  11.2.1 US
    11.2.1.1 Strong economy and increasing R&D expenditure are expected to drive the growth of the life science analytics market in the US
  11.2.2 CANADA
    11.2.2.1 Rising need for data standardization in the life science industry to support market growth in Canada
11.3 EUROPE
  11.3.1 GERMANY
    11.3.1.1 Growing R&D investments by pharmaceutical and biotechnology companies to drive market growth in Germany
  11.3.2 FRANCE
    11.3.2.1 Growing government support for the adoption of AI and big data analytics to drive market growth in France
  11.3.3 UK
    11.3.3.1 UK to dominate the European life science analytics market during the forecast period
  11.3.4 REST OF EUROPE
11.4 ASIA
  11.4.1 JAPAN
    11.4.1.1 Growing government support for clinical R&D activities to drive the demand for analytics solutions in Japan
  11.4.2 CHINA
    11.4.2.1 Growth of the life science industry to drive market growth in China
  11.4.3 INDIA
    11.4.3.1 Rising R&D budgets and growing number of drug development-based research activities to support market growth in India
  11.4.4 REST OF ASIA
11.5 REST OF THE WORLD

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 MARKET PLAYER RANKING
12.3 COMPETITIVE LEADERSHIP MAPPING–OVERALL MARKET
  12.3.1 VISIONARY LEADERS
  12.3.2 DYNAMIC DIFFERENTIATORS
  12.3.3 INNOVATORS
  12.3.4 EMERGING PLAYERS
12.4 COMPETITIVE SITUATION AND TRENDS
  12.4.1 PRODUCT LAUNCHES
  12.4.2 EXPANSIONS
  12.4.3 ACQUISITIONS
  12.4.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATION

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 SAS INSTITUTE INC.
13.2 IBM CORPORATION
13.3 ORACLE CORPORATION
13.4 IQVIA
13.5 ACCENTURE
13.6 COGNIZANT
13.7 MAXISIT
13.8 SCIO HEALTH ANALYTICS
13.9 TAKE SOLUTIONS
13.10 WIPRO LIMITED
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 2 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 3 NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 4 EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 PREDICTIVE ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 12 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 13 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 15 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 EUROPE: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 PRECLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 EUROPE: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 27 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2017–2024 (USD MILLION)
TABLE 29 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 35 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 36 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 39 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 42 ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 43 NORTH AMERICA: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 45 ON-DEMAND SOLUTIONS OFFERED IN THE MARKET
TABLE 46 ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 47 NORTH AMERICA: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 48 EUROPE: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 49 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 51 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 52 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 53 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 54 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 55 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 56 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 57 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 58 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2017–2024 (USD MILLION)
TABLE 60 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 61 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 63 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 64 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 65 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 66 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 68 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 69 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 70 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 71 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 72 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 74 US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 75 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 76 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 77 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 78 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 80 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 81 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 82 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 83 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 84 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 85 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 87 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 88 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 89 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 90 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 91 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 93 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 94 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 95 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 96 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 97 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 99 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 100 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 101 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 102 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 103 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 104 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 105 UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 106 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 107 ROE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 108 ROE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 109 ROE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 110 ROE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 111 ROE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 112 ROE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 113 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 114 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 115 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 116 ASIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 118 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 119 ASIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 120 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 121 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 122 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 123 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 124 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 125 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 126 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 127 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 128 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 129 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 130 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 131 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 132 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 133 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 134 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 135 ROA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 136 ROA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 137 ROA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 138 ROA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 139 ROA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 140 ROW: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 ROW: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 142 ROW: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017–2024 (USD MILLION)
TABLE 143 ROW: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017–2024 (USD MILLION)
TABLE 144 ROW: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017–2024 (USD MILLION)
TABLE 145 ROW: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 146 LIFE SCIENCE ANALYTICS MARKET PLAYER RANKING, 2018
TABLE 147 PRODUCT LAUNCHES, 2016–2019
TABLE 148 EXPANSIONS, 2016–2019
TABLE 149 ACQUISITIONS, 2015–2019
TABLE 150 OTHER STRATEGIES, 2015–2019

LIST OF FIGURES

FIGURE 1 LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
FIGURE 8 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
FIGURE 9 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2019 VS. 2024 (USD BILLION)
FIGURE 10 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2019 VS. 2024 (USD BILLION)
FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2019 VS. 2024 (USD BILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS ARE DRIVING MARKET GROWTH
FIGURE 14 DESCRIPTIVE ANALYTICS TO DOMINATE THE LIFE SCIENCE ANALYTICS
MARKET IN 2019
FIGURE 15 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE LIFE SCIENCE ANALYTICS END-USER MARKET IN 2019
FIGURE 16 ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 17 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 HEALTHCARE SPENDING AS A PERCENTAGE OF THE GDP, BY COUNTRY, 2017
FIGURE 19 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
FIGURE 20 EUROPE: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
FIGURE 21 ASIA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
FIGURE 22 KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET FROM 2016 TO OCTOBER 2019
FIGURE 23 COMPETITIVE LEADERSHIP MAPPING OF THE LIFE SCIENCE ANALYTICS MARKET OVERALL MARKET
FIGURE 24 COMPANY SNAPSHOT: SAS INSTITUTE INC. (2017)
FIGURE 25 COMPANY SNAPSHOT: IBM CORPORATION (2018)
FIGURE 26 COMPANY SNAPSHOT: ORACLE CORPORATION (2018)
FIGURE 27 COMPANY SNAPSHOT: IQVIA (2018)
FIGURE 28 COMPANY SNAPSHOT: ACCENTURE (2018)
FIGURE 29 COMPANY SNAPSHOT: COGNIZANT (2018)
FIGURE 30 COMPANY SNAPSHOT: TAKE SOLUTIONS (2016)
FIGURE 31 COMPANY SNAPSHOT: WIPRO LIMITED (2018)


More Publications